Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

TransEnterix Inc. (TRXC)

1.49   -0.13 (-8.02%) 01-17 16:00
Open: 1.59 Pre. Close: 1.62
High: 1.62 Low: 1.48
Volume: 1,373,757 Market Cap: 31M
TransEnterix Inc is a medical device company engaged in the development and commercialization of a robotic assisted surgical system called the SurgiBot System.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.622 - 1.631 1.631 - 1.638
Low: 1.46 - 1.47 1.47 - 1.479
Close: 1.474 - 1.49 1.49 - 1.503

Technical analysis

as of: 2020-01-17 4:40:35 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.49     One year: 3.06
Support: Support1: 1.35    Support2: 1.12
Resistance: Resistance1: 2.13    Resistance2: 2.62
Pivot: 1.51
Moving Average: MA(5): 1.56     MA(20): 1.51
MA(100): 4.73     MA(250): 16.21
MACD: MACD(12,26): -0.21     Signal(9): -0.29
Stochastic oscillator: %K(14,3): 17.72     %D(3): 19.80
RSI: RSI(14): 36.83
52-week: High: 43.29  Low: 1.35  Change(%): -95.7
Average Vol(K): 3-Month: 107261  10-Days: 425011

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TRXC has closed above bottom band by 43.2%. Bollinger Bands are 90.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to TRXC's normal range. The bands have been in this narrow range for 48 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

TransEnterix Announces Submission of 510(k) to FDA for First Machine Vision System in Robotic Surgery
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company filed a 510(k) submission with an Intelligent Surgical Unit (ISUTM)1 that is designed to enable machine vision capabilities on the SenhanceⓇ Surgical System. “TransEnterix is the first company to seek FDA clearance for machine vision technology in a

TransEnterix Announces Ochsner Health System to Initiate Program with the Senhance Surgical System
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Ochsner Health System has entered into an agreement to lease and utilize a Senhance® System that has been installed at the Ochsner Baptist* facility. This placement is one of the two placements referenced in the Company’s January 6, 2020 press release.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Medical Instruments Supplies
Shares Out. (M) 19.67
Shares Float (M) 17.60
% Held by Insiders 10.40
% Held by Institutions 29.17
Shares Short (K) 1860
Shares Short P. Month (K)

Stock Financials

EPS -8.877
Book Value (p.s.) 3.240
PEG Ratio
Profit Margin
Operating Margin -546.05
Return on Assets (ttm) -32.3
Return on Equity (ttm) -129.0
Qtrly Rev. Growth -62.7
Gross Profit (p.s.) 0.403
Sales Per Share
EBITDA (p.s.) -3.627
Qtrly Earnings Growth
Operating Cash Flow (M) -71.97
Levered Free Cash Flow (M) -29.95

Stock Valuations

P/E -0.17
P/E Growth Ratio -0.08
P/BV 0.46
P/S 1.63
P/CF -0.41

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-12-12
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.